Clinical Trials · NCT05339529
Protective Effect of Thymosin Α1 Against Negative Immune Dysregulation and Organ Dysfunction After Acute Aortic Dissection Surgery (PANDA II)
- Phase
- N/A
- Recruitment status
- Recruiting
- Sponsor
- Nanjing Medical University
- Enrollment
- 330
- Start date
- Jul 2022
- Locations
- 15 sites, China
- Primary endpoint
- The highest Sequential Organ Failure Assessment (SOFA) score of 7 days after surgery